M. Veness

Insider Reports History

Entity
Individual
Location
C/O Dianthus Therapeutics, Inc., 7 Times Square, 43 Rd Floor, New York, New York
Signature
/s/ Adam Veness
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by M. Veness:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Cyteir Therapeutics, Inc. General Counsel Stock Option (Right to Buy) 96.1K Feb 3, 2023 Direct
Dianthus Therapeutics, Inc. /DE/ SVP, General Counsel and Sec. Stock Option (Right to Buy) 75K May 23, 2024 Direct
ACCELERON PHARMA INC SVP, General Counsel and Sec. Common Stock 0 $29.37 Nov 19, 2021 Direct
ACCELERON PHARMA INC SVP, General Counsel and Sec. Option to Purchase Common Stock 0 Nov 19, 2021 Direct

Insider Reports Filed by M. Veness

Symbol Company Period Transactions Value $ Form Type Date Filed Role
DNTH Dianthus Therapeutics, Inc. /DE/ May 23, 2024 1 $0 4 May 28, 2024 SVP, General Counsel and Sec.
DNTH Dianthus Therapeutics, Inc. /DE/ Jan 24, 2024 1 $0 4 Jan 26, 2024 SVP, General Counsel and Sec.
MGTA Dianthus Therapeutics, Inc. /DE/ Sep 11, 2023 0 $0 3 Sep 13, 2023 SVP, GENERAL COUNSEL & SECRETARY Exhibit 24 - Power of Attorney
CYT Cyteir Therapeutics, Inc. Feb 3, 2023 1 $0 4 Feb 7, 2023 General Counsel
CYT Cyteir Therapeutics, Inc. May 2, 2022 1 $0 4 May 4, 2022 General Counsel
CYT Cyteir Therapeutics, Inc. Apr 25, 2022 0 $0 3 May 4, 2022 General Counsel
XLRN ACCELERON PHARMA INC Nov 19, 2021 6 $0 4 Nov 22, 2021 SVP, General Counsel and Sec.
XLRN ACCELERON PHARMA INC Nov 9, 2021 2 $132K 4 Nov 12, 2021 SVP, General Counsel and Sec.
XLRN ACCELERON PHARMA INC Sep 21, 2021 5 -$781K 4 Sep 22, 2021 SVP, General Counsel and Sec.
XLRN ACCELERON PHARMA INC Sep 7, 2021 3 -$260K 4 Sep 9, 2021 SVP, General Counsel and Sec.
XLRN ACCELERON PHARMA INC Jun 7, 2021 1 -$13.7K 4 Jun 8, 2021 SVP, General Counsel and Sec.